Recent tau-targeted clinical strategies for the treatment of Alzheimer's disease

Ha E. Lee; Dami Lim; Jae Y. Lee; Sang M. Lim; Ae N. Pae

doi:10.4155/fmc-2019-0151

Recent tau-targeted clinical strategies for the treatment of Alzheimer's disease

Ha E. Lee, Dami Lim, Jae Y. Lee, Sang M. Lim, Ae N. Pae

Research output: Contribution to journal › Review article › peer-review

19 Citations (Scopus)

Original language	English
Pages (from-to)	1845-1848
Number of pages	4
Journal	Future Medicinal Chemistry
Volume	11
Issue number	16
DOIs	https://doi.org/10.4155/fmc-2019-0151
Publication status	Published - 2019

Bibliographical note

Funding Information:
This work was supported by the National Research Council of Science & Technology grant by the Korea government (MSIP) (no. CRC-15-04-KIST). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.

Keywords

Alzheimer's disease
acetylation
aggregation
deglycosylation
immunotherapy
tau

Access to Document

10.4155/fmc-2019-0151

Cite this

@article{b47b2bf9025a4214834f4db39e2f9347,

title = "Recent tau-targeted clinical strategies for the treatment of Alzheimer's disease",

keywords = "Alzheimer's disease, acetylation, aggregation, deglycosylation, immunotherapy, tau",

author = "Lee, {Ha E.} and Dami Lim and Lee, {Jae Y.} and Lim, {Sang M.} and Pae, {Ae N.}",

note = "Funding Information: This work was supported by the National Research Council of Science & Technology grant by the Korea government (MSIP) (no. CRC-15-04-KIST). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",

year = "2019",

doi = "10.4155/fmc-2019-0151",

language = "English",

volume = "11",

pages = "1845--1848",

journal = "Future Medicinal Chemistry",

issn = "1756-8919",

publisher = "Taylor and Francis Ltd.",

number = "16",

}

TY - JOUR

T1 - Recent tau-targeted clinical strategies for the treatment of Alzheimer's disease

AU - Lee, Ha E.

AU - Lim, Dami

AU - Lee, Jae Y.

AU - Lim, Sang M.

AU - Pae, Ae N.

N1 - Funding Information: This work was supported by the National Research Council of Science & Technology grant by the Korea government (MSIP) (no. CRC-15-04-KIST). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

PY - 2019

Y1 - 2019

KW - Alzheimer's disease

KW - acetylation

KW - aggregation

KW - deglycosylation

KW - immunotherapy

KW - tau

UR - http://www.scopus.com/inward/record.url?scp=85072144945&partnerID=8YFLogxK

U2 - 10.4155/fmc-2019-0151

DO - 10.4155/fmc-2019-0151

M3 - Review article

C2 - 31517533

AN - SCOPUS:85072144945

SN - 1756-8919

VL - 11

SP - 1845

EP - 1848

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

IS - 16

ER -

Recent tau-targeted clinical strategies for the treatment of Alzheimer's disease

Bibliographical note

Keywords

Access to Document

Other files and links

Cite this